Bezos backs startup aimed at delaying age-related diseases

( By Julie Spitzer for Becker’s Hospital Review)

Among the investors backing Unity Biotechnology, a startup that aims to develop drugs to extend the human lifespan, is Amazon founder and CEO Jeff Bezos, CNBC reports. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.